GlassScriptPhysician profile
Sean D Mcwilliams
NPI 1356323398
$139,029.10
in general payments reported to CMS, 2019-2025
10 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Phlebology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,882 · 2020: $9,918 · 2021: $2,728 · 2022: $12K · 2023: $85K · 2024: $19K · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $58K · Debt Forgiveness: $46K · Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $57,600.00 |
| Debt Forgiveness | $46,220.00 |
| Food and Beverage | $624.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $137,420.00 | 2019-2024 | Venacure Evlt, Venacure 1470 Pro |
| Tactile Systems Technology INC | $934.60 | 2019-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Koya Medical, INC. | $267.30 | 2024-2025 | Dayspring, Koya Medical, Dayspring |
| Medtronic Vascular, INC. | $227.70 | 2019-2020 | |
| Medtronic, INC. | $54.03 | 2021-2025 | Venaseal |
| Boston Scientific Corporation | $40.23 | 2025 | Varithena Administration Pack |
| Mimedx Group, INC. | $26.26 | 2025 | |
| Cashflow Solutions, LLC | $23.12 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Glaxosmithkline, LLC. | $20.01 | 2025 | Nucala |
| Janssen Pharmaceuticals, INC | $15.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mcwilliams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.